The ROE as of December 2025 (TTM) for Hansa Biopharma AB (publ) (HNSBF) is 115.70%

According to Hansa Biopharma AB (publ)’s latest financial reports and current stock price. The company's current ROE is 115.70%. This represents a change of 286.15% compared to the average of 29.96% of the last 4 quarters.

Hansa Biopharma AB (publ) (HNSBF) Historical ROE (quarterly & annually)

How has HNSBF ROE performed in the past?

The mean historical ROE of Hansa Biopharma AB (publ) over the last ten years is 23.34%. The current 115.70% ROE has changed 395.79% with respect to the historical average. Over the past ten years (40 quarters), HNSBF's ROE was at its highest in in the September 2023 quarter at 402.94%. The ROE was at its lowest in in the June 2023 quarter at -137.87%.

Hansa Biopharma AB (publ) (HNSBF) ROE by Quarter and Year

Discovering the peaks and valleys of Hansa Biopharma AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hansa Biopharma AB (publ) (HNSBF) Average ROE

How has HNSBF ROE performed in the past?

The current ROE of Hansa Biopharma AB (publ) (HNSBF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Hansa Biopharma AB (publ) (HNSBF) ROE vs. Peers

How is HNSBF’s ROE compared to its peers?

Hansa Biopharma AB (publ)’s ROE is greater than Silence Therapeutics plc (-85.88%), greater than Transgene S.A. (-634.16%), greater than Probi AB (publ) (0.84%), greater than Cellectis S.A. (-49.81%), greater than Santhera Pharmaceuticals Holding AG (-521.53%), greater than Immutep Limited (-38.87%), greater than Genfit S.A. (-63.70%), greater than Frontage Holdings Corporation (1.14%), less than hVIVO plc (25.62%), greater than Mayne Pharma Group Limited (-22.99%),

Build a custom stock screener for Hansa Biopharma AB (publ) (HNSBF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hansa Biopharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hansa Biopharma AB (publ) (HNSBF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hansa Biopharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.